| P2093 | author name string | Yasuko Mori | |
| | Michiaki Takahashi | |
| | Koichi Yamanishi | |
| | Yasuyuki Gomi | |
| | Kazuhiro Nagaike | |
| | Hiroki Sunamachi | |
| P2860 | cites work | Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients | Q33445140 |
| | Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates | Q33797732 |
| | Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase | Q33798767 |
| | Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products | Q33846286 |
| | Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates | Q33864696 |
| | Regulation of varicella-zoster virus gene expression in human T lymphocytes | Q33935067 |
| | Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse | Q34069075 |
| | The complete DNA sequence of varicella-zoster virus | Q34162480 |
| | Live vaccine used to prevent the spread of varicella in children in hospital | Q34202755 |
| | Mutational analysis of varicella-zoster virus major immediate-early protein IE62. | Q34746607 |
| | Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndrome | Q35313179 |
| | The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse | Q36327713 |
| | Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro | Q36465730 |
| | Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates | Q36541833 |
| | Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression. | Q36643668 |
| | Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters | Q36645576 |
| | Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. | Q36650469 |
| | A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain. | Q36650787 |
| | The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles | Q36656146 |
| | The unique sequence of the herpes simplex virus 1 L component contains an additional translated open reading frame designated UL49.5 | Q36656428 |
| | The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter | Q36668058 |
| | Role of herpes simplex virus type 1 UL46 and UL47 in alpha TIF-mediated transcriptional induction: characterization of three viral deletion mutants | Q36680255 |
| | The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters | Q36681570 |
| | Analysis of the UL36 open reading frame encoding the large tegument protein (ICP1/2) of herpes simplex virus type 1 | Q36687637 |
| | Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates | Q36690631 |
| | Generation of an inverting herpes simplex virus 1 mutant lacking the L-S junction a sequences, an origin of DNA synthesis, and several genes including those specifying glycoprotein E and the alpha 47 gene | Q36862990 |
| | Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. | Q36869202 |
| | Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). | Q36918734 |
| | Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression | Q39604242 |
| | Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking | Q39882103 |
| | Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region | Q40007098 |
| | Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA. | Q40130302 |
| | Mutation of a single lysine residue severely impairs the DNA recognition and regulatory functions of the VZV gene 62 transactivator protein | Q40224871 |
| | The DNA binding domain of the varicella-zoster virus gene 62 protein interacts with multiple sequences which are similar to the binding site of the related protein of herpes simplex virus type 1. | Q40404992 |
| | Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. | Q40560359 |
| | Experimental infection and immune response of guinea pigs with varicella-zoster virus | Q40598047 |
| | Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses | Q40807931 |
| | Regulated nuclear localization of the varicella-zoster virus major regulatory protein, IE62. | Q40988414 |
| | Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis | Q41028258 |
| | Enhancement of varicella-zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins | Q41177944 |
| | A herpes simplex virus type 1 recombinant with both copies of the Vmw175 coding sequences replaced by the homologous varicella-zoster virus open reading frame | Q41202251 |
| | The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter | Q41597238 |
| | Characterization of the large tegument protein (ICP1/2) of herpes simplex virus type 1 | Q41606757 |
| | The product of varicella-zoster virus gene 62 autoregulates its own promoter | Q41712292 |
| | Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion | Q41840173 |
| | An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products | Q42597618 |
| | Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. | Q42603228 |
| | A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V) | Q42613583 |
| | Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity | Q42629904 |
| | Differential regulation by varicella-zoster virus (VZV) and herpes simplex virus type-1 trans-activating genes | Q42642472 |
| | A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus | Q43449917 |
| | Identification of a varicella-zoster virus origin of DNA replication and its activation by herpes simplex virus type 1 gene products | Q44250136 |
| | The TATA motif specifies the differential activation of minimal promoters by varicella zoster virus immediate-early regulatory protein IE62. | Q45745359 |
| | Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction | Q45749773 |
| | Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world | Q45752330 |
| | Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts | Q45760098 |
| | Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain | Q45760545 |
| | Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro | Q45760996 |
| | Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother | Q45761229 |
| | Typing of varicella zoster virus by amplification of DNA polymorphisms | Q45768341 |
| | Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction | Q45778236 |
| | Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults | Q45835308 |
| | Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI. | Q45836224 |
| | Immune response of guinea pigs to varicella vaccine strain (OKA) and wild strains | Q46538643 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 11447-11459 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus | |
| P478 | volume | 76 | |